期刊文献+

靶向表皮生长因子受体和血管内皮生长因子受体-2治疗多形性胶质母细胞瘤 被引量:6

The inhibitive effect of targeting epidermal growth factor receptor and vascular endothelial growth factor receptor-2 on transplanted human glioblastoma multiforme in nude mice
原文传递
导出
摘要 目的观察靶向表皮生长因子受体(EGFR)的单克隆抗体C225和靶向血管内皮生长因子受体.2(VEGFR-2)的单克隆抗体DC101单独或联合应用后对人脑多形性胶质母细胞瘤(GBM)裸小鼠脑内移植瘤的疗效。方法将40只荷瘤鼠随机分为磷酸盐缓冲液(PBS,0.1mL/20g·次)、C225(50mg/kg·次)、DC101(40mg/kg·次)及C225+DC101(50+40mg/kg·次)等4组,10只/每组,2d1次腹腔用药或PBS,共4次。治疗后观察移植瘤微血管密度(MVD)、体积、形态、增殖和凋亡变化。结果与对照组比较,DC101组移植瘤MVD减少了64.0%,体积下降了59.7%,增殖指数下降了53.2%,凋亡指数增加了66.7%(P〈0.05),但肿瘤侵袭性增强;C225组肿瘤侵袭性降低,但对移植瘤MVD、体积、增殖和凋亡无影响(P〉0.05);C225+DC101组移植瘤MVD减少了68.0%,体积下降了62.9%,增殖指数下降了56.4%,凋亡指数增加了75.0%(P〈0.05),肿瘤侵袭性明显下降。结论DC101抑制血管生成同时增加了肿瘤的侵袭性,而C225能降低肿瘤侵袭性。联合用药不仅抑制GBM移植瘤生长还降低肿瘤侵袭能力。 Objective To explore the inhibitive effect on transplanted human glioblastoma multiforme in the brain of nude mice after treatment of C225 targeting the epidermal growth factor receptor ( EGFR) and DC101 targeting the vascular endothelial cell growth factor receptor (VEGFR2) alone and combined application. Methods Forty mice bearing xenografts were divided into 4 groups randomly with 10 every group, then 4 groups of mice received i.p. injections of C225 (50 mg/kg) , DC101 (40 mg/kg) , C225 + DC101 or PBS (0.1 ml/20 g) respectively 4 times, once every 2 days. On the day 14 post-treatment, mice were sacrificed. Murine brains were removed and fixed in formalin, then tumor appearance and volume were observed, meanwhile microvessel density, proliferation and apoptosis index were also detected by immunohistochemical or TUNEL methods. Results Compared with the control group, tumor volume was decreased by 59.7% , microvessel density was decreased by 64.0% , KI-67 LI was decreased by 53.2% , and AI was increased by 66.7% in DC101 group (P 〈0.05 ) , but tumor invasiveness was increased ; C225 could reduce tumor invasiveness, but had no effect on the volume, Ki-67 LI or AI of tumor ( P 〉 0. 05 ) ; Tumor volume was decreased by 62.9% ( P 〈0. 05 ), microvessel density was decreased by 68.0% , Ki-67 LI was decreased by 56.4% and AI was increased by 75% in C225 + DC101 group (P 〈 0.05) , invasiveness was also decreased significantly. Conclusion DC101 could inhabit the angiogenesis, and simultaneously could increase the tumor invasiveness, while the C225 could reduce tumor invasiveness. Combined of DC101 and C225 could significantly inhibit GBM tumor growth and reduce the capacity of tumor invasion as compared with DC101 or C255 used alone.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第3期358-360,共3页 Chinese Journal of Experimental Surgery
关键词 表皮生长因子受体 血管内皮生长因子受体-2 分子靶向治疗 胶质瘤 EGFR VEGFR-2 Molecular targeted therapy Glioma muhiforme
  • 相关文献

参考文献12

  • 1Karpel-Massler G,Schmidt U,Unterberg A,et al.Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas:where do we stand?Mol Cancer Res,2009,7:1000-1012. 被引量:1
  • 2Kerbel RS.Tumor angiogenesis:past,present and near future.Carcinogenesis,2000,21:505-515. 被引量:1
  • 3康春生,浦佩玉,张志勇,王广秀,贾志凡,裘明哲,原续波,常津.反义表皮生长因子受体RNA对U251胶质瘤细胞生长的抑制作用[J].中华实验外科杂志,2006,23(1):75-77. 被引量:24
  • 4Lamszus K,Kunkel P,Westphal M.Invasion as limitation to anti-angiogenix glioma therapy.Acta Neurochir Suppl,2003,88:169-177. 被引量:1
  • 5Prewett M,Huber J,Li Y,et al.Antivascular endothelial growth factor receptor(fetal liver kinase 1)monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.Cancer Res,1999,59:5209-5218. 被引量:1
  • 6刁艺,黄强,董军,李如军,兰青.人脑胶质母细胞瘤组织异种原位移植模型建立[J].中华实验外科杂志,2008,25(4):534-534. 被引量:5
  • 7Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.Clin Cancer Res,2004,10:1255-1262. 被引量:1
  • 8Burkhardt M,Mayordomo E,Winzer KJ,et al.Cytoplasmic overexpression of ALCAM is prognostic of disease progressionin breast cancer.J Clin Pathol,2006,59:403-409. 被引量:1
  • 9Shu Q,Wong KK,Su JM,et al.Direct orthotopic transplantation of fresh surgical specimen preserves CD133~+ tumor cells in dinically relevant mouse models of medulloblastoma and glioma.Stem Cell,2008,26:1414-1424. 被引量:1
  • 10Maeda K,Chung YS,Takatsuka s,et al.Tumor angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma.Br J Cancer,1995,72:319-323. 被引量:1

二级参考文献11

共引文献26

同被引文献57

  • 1Kypros Zenonos,Katy Kyprianou.RAS signaling pathways, mutations and their role in colorectal cancer[J].World Journal of Gastrointestinal Oncology,2013,5(5):97-101. 被引量:8
  • 2康春生,浦佩玉,张志勇,王广秀,贾志凡,裘明哲,原续波,常津.反义表皮生长因子受体RNA对U251胶质瘤细胞生长的抑制作用[J].中华实验外科杂志,2006,23(1):75-77. 被引量:24
  • 3Read RD, Cavenee WK, Furnari FB, et al. A drosophila model for EGFR -Ras and PI3K -dependent human glioma. PLoS Genet, 2009, 5:e1000374. 被引量:1
  • 4Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol,2005,23:2445-2459. 被引量:1
  • 5Monami G,Gonzalez EM,Hellman M,et al. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERKI /2 and the formation of a paxillin/FAK/ERK complex .Cancer Res,2006,66:7103 -4110. 被引量:1
  • 6Levizki A , Gazit A. Tyrosine kinase inhibition : an approach to drug development . Science,1996,28:1255-1259. 被引量:1
  • 7Nagane M, Narita Y, Mishima K, et al. Human glioblastoma xenografts overexpressing a tumour-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. J Neurosurg,2001,95:472-479. 被引量:1
  • 8Perera RM, Narita Y, Furnari FB, et al. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. Clin Cancer Res,2005,11: 6390-6399. 被引量:1
  • 9Chakravarti A, Chakladar A, Delaney MA, et al. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res,2002,62:4307-4315. 被引量:1
  • 10Paccapelo A,Piana C,Rychlicki F,et al.Treatment of malignant gliomas:a new approach.Tumori,1998,84:529-533. 被引量:1

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部